Allan-Herndon-Dudley Syndrome Latest Advances

When Neuromotor Delay Meets Thyroid Dysfunction: A Case for Considering Allan-Herndon-Dudley Syndrome.

Journal: Klinische Padiatrie

Published: November 21, 2025

Thyroid Hormones Act as a Timer for the Postnatal Maturation of Parvalbumin Neurons in Mouse Neocortex.

Journal: Thyroid : official journal of the American Thyroid Association

Published: November 07, 2025

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

Journal: European thyroid journal

Published: August 20, 2025

Novel MCT8 mutation: diagnostic value of T3/T4 ratio.

Journal: Journal of pediatric endocrinology & metabolism : JPEM

Published: August 09, 2025

MCT8 Deficiency in Infancy: Opportunities for Early Diagnosis and Screening.

Journal: International journal of neonatal screening

Published: June 16, 2025

Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?

Journal: International journal of neonatal screening

Published: May 28, 2025

Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?

Journal: European thyroid journal

Published: May 20, 2025

Tiratricol: First Approval.

Journal: Drugs

Published: May 04, 2025

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: March 29, 2025

The phenotypic spectrum of individuals with SLC16A2 variants in MCT8 deficiency.

Journal: HGG advances

Published: March 25, 2025

Correction of the Allan-Herndon-Dudley syndrome-causing SLC16A2 mutation G401R in a patient derived hiPSC line.

Journal: Stem cell research

Published: February 24, 2025

Generation of two human induced pluripotent stem cell lines from Allan-Herndon-Dudley syndrome (AHDS) patients with SLC16A2:G401R or SLC16A2: H192R mutation.

Journal: Stem cell research

Published: February 21, 2025

Filters

When Neuromotor Delay Meets Thyroid Dysfunction: A Case for Considering Allan-Herndon-Dudley Syndrome.

When Neuromotor Delay Meets Thyroid Dysfunction: A Case for Considering Allan-Herndon-Dudley Syndrome.

Thyroid Hormones Act as a Timer for the Postnatal Maturation of Parvalbumin Neurons in Mouse Neocortex.

Thyroid Hormones Act as a Timer for the Postnatal Maturation of Parvalbumin Neurons in Mouse Neocortex.

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

Reply to the letter by Dr Karlsson 'Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?'

Novel MCT8 mutation: diagnostic value of T3/T4 ratio.

Novel MCT8 mutation: diagnostic value of T3/T4 ratio.

MCT8 Deficiency in Infancy: Opportunities for Early Diagnosis and Screening.

MCT8 Deficiency in Infancy: Opportunities for Early Diagnosis and Screening.

Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?

Is It Time to Expand Newborn Screening for Congenital Hypothyroidism to Other Rare Thyroid Diseases?

Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?

Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan-Herndon-Dudley syndrome with tiratricol?

Tiratricol: First Approval.

Tiratricol: First Approval.

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency.

The phenotypic spectrum of individuals with SLC16A2 variants in MCT8 deficiency.

The phenotypic spectrum of individuals with SLC16A2 variants in MCT8 deficiency.

Correction of the Allan-Herndon-Dudley syndrome-causing SLC16A2 mutation G401R in a patient derived hiPSC line.

Correction of the Allan-Herndon-Dudley syndrome-causing SLC16A2 mutation G401R in a patient derived hiPSC line.

Generation of two human induced pluripotent stem cell lines from Allan-Herndon-Dudley syndrome (AHDS) patients with SLC16A2:G401R or SLC16A2: H192R mutation.

Generation of two human induced pluripotent stem cell lines from Allan-Herndon-Dudley syndrome (AHDS) patients with SLC16A2:G401R or SLC16A2: H192R mutation.